Steward Partners Investment Advisory, LLC Bicycle Therapeutics PLC Transaction History
Steward Partners Investment Advisory, LLC
- $11 Billion
- Q4 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 10 shares of BCYC stock, worth $124. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10Holding current value
$124% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BCYC
# of Institutions
109Shares Held
41.7MCall Options Held
39.6KPut Options Held
24.6K-
Baker Bros. Advisors LP New York, NY9.4MShares$117 Million2.28% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.61MShares$32.6 Million0.17% of portfolio
-
Fcpm Iii Services B.V. Naarden, P72.34MShares$29.2 Million9.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA2.25MShares$28.1 Million0.71% of portfolio
-
Armistice Capital, LLC New York, NY1.96MShares$24.4 Million0.74% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $371M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...